| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACTB
|
actin, beta
|
|
ACTL6A
|
actin-like 6A
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADCY7
|
adenylate cyclase 7
|
|
ADCY9
|
adenylate cyclase 9
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGRN
|
agrin
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AIDA
|
axin interactor, dorsalization associated
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA3
|
annexin A3
|
|
ANXA4
|
annexin A4
|
|
ANXA5
|
annexin A5
|
|
ANXA6
|
annexin A6
|
|
ANXA8
|
annexin A8
|
|
ANXA8L1
|
annexin A8-like 1
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AQP7
|
aquaporin 7
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARHGAP24
|
Rho GTPase activating protein 24
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARID3A
|
AT rich interactive domain 3A (BRIGHT-like)
|
|
ARSD
|
arylsulfatase D
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASB2
|
ankyrin repeat and SOCS box containing 2
|
|
ASMTL
|
acetylserotonin O-methyltransferase-like
|
|
ASPG
|
asparaginase
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ASXL2
|
additional sex combs like transcriptional regulator 2
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATN1
|
atrophin 1
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN1
|
ataxin 1
|
|
AURKB
|
aurora kinase B
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCOR
|
BCL6 corepressor
|
|
BCORL1
|
BCL6 corepressor-like 1
|
|
BCR
|
breakpoint cluster region
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLZF1
|
basic leucine zipper nuclear factor 1
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD4
|
bromodomain containing 4
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBR1
|
carbonyl reductase 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD19
|
CD19 molecule
|
|
CD2
|
CD2 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD52
|
CD52 molecule
|
|
CD6
|
CD6 molecule
|
|
CD68
|
CD68 molecule
|
|
CD84
|
CD84 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK20
|
cyclin-dependent kinase 20
|
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKL1
|
cyclin-dependent kinase-like 1 (CDC2-related kinase)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CENPV
|
centromere protein V
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CGB8
|
chorionic gonadotropin, beta polypeptide 8
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
|
CHMP5
|
charged multivesicular body protein 5
|
|
CHPT1
|
choline phosphotransferase 1
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLEC4D
|
C-type lectin domain family 4, member D
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTNAP1
|
contactin associated protein 1
|
|
COX1
|
|
|
CPOX
|
coproporphyrinogen oxidase
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRLF3
|
cytokine receptor-like factor 3
|
|
CRYBA1
|
crystallin, beta A1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CST3
|
cystatin C
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTSG
|
cathepsin G
|
|
CTSH
|
cathepsin H
|
|
CTSZ
|
cathepsin Z
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
DAP
|
death-associated protein
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DAXX
|
death-domain associated protein
|
|
DCTN4
|
dynactin 4 (p62)
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DEK
|
DEK proto-oncogene
|
|
DERL2
|
derlin 2
|
|
DHDDS
|
dehydrodolichyl diphosphate synthase
|
|
DHX15
|
DEAH (Asp-Glu-Ala-His) box helicase 15
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DRAM2
|
DNA-damage regulated autophagy modulator 2
|
|
DTNA
|
dystrobrevin, alpha
|
|
E2F1
|
E2F transcription factor 1
|
|
EBP
|
emopamil binding protein (sterol isomerase)
|
|
EFNA4
|
ephrin-A4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EHD3
|
EH-domain containing 3
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EOMES
|
eomesodermin
|
|
EP300
|
E1A binding protein p300
|
|
EPHB2
|
EPH receptor B2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETV6
|
ets variant 6
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F13B
|
coagulation factor XIII, B polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F9
|
coagulation factor IX
|
|
FANCB
|
Fanconi anemia, complementation group B
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF13
|
fibroblast growth factor 13
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FH
|
fumarate hydratase
|
|
FHL2
|
four and a half LIM domains 2
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC1
|
forkhead box C1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXYD6
|
FXYD domain containing ion transport regulator 6
|
|
FZD9
|
frizzled class receptor 9
|
|
G0S2
|
G0/G1 switch 2
|
|
GABARAPL2
|
GABA(A) receptor-associated protein-like 2
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GAS2L1
|
growth arrest-specific 2 like 1
|
|
GATA2
|
GATA binding protein 2
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GHR
|
growth hormone receptor
|
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog)
|
|
GLB1
|
galactosidase, beta 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GORASP1
|
golgi reassembly stacking protein 1, 65kDa
|
|
GPR180
|
G protein-coupled receptor 180
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPSM3
|
G-protein signaling modulator 3
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTK1
|
glutathione S-transferase kappa 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2H1
|
general transcription factor IIH, polypeptide 1, 62kDa
|
|
GTF2I
|
general transcription factor IIi
|
|
H1F0
|
H1 histone family, member 0
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC9
|
histone deacetylase 9
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST1H1C
|
histone cluster 1, H1c
|
|
HK3
|
hexokinase 3 (white cell)
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HMGN2
|
high mobility group nucleosomal binding domain 2
|
|
HNMT
|
histamine N-methyltransferase
|
|
HOXA1
|
homeobox A1
|
|
HOXA9
|
homeobox A9
|
|
HOXB2
|
homeobox B2
|
|
HOXC5
|
homeobox C5
|
|
HOXD3
|
homeobox D3
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IER3
|
immediate early response 3
|
|
IFI30
|
interferon, gamma-inducible protein 30
|
|
IFNG
|
interferon, gamma
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRF9
|
interferon regulatory factor 9
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3B
|
lysine (K)-specific demethylase 3B
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KLRC4-KLRK1
|
KLRC4-KLRK1 readthrough
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRBOX4
|
KRAB box domain containing 4
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMTOR2
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
|
|
LBR
|
lamin B receptor
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS12
|
lectin, galactoside-binding, soluble, 12
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LMNB2
|
lamin B2
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MARCKSL1
|
MARCKS-like 1
|
|
MATN1
|
matrilin 1, cartilage matrix protein
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD3
|
methyl-CpG binding domain protein 3
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEIS1
|
Meis homeobox 1
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFAP1
|
microfibrillar-associated protein 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MPST
|
mercaptopyruvate sulfurtransferase
|
|
MRE11
|
MRE11 homolog, double strand break repair nuclease
|
|
MRPL28
|
mitochondrial ribosomal protein L28
|
|
MSC
|
musculin
|
|
MSH3
|
mutS homolog 3
|
|
MSTO1
|
misato 1, mitochondrial distribution and morphology regulator
|
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MZF1
|
myeloid zinc finger 1
|
|
NABP1
|
nucleic acid binding protein 1
|
|
NAE1
|
NEDD8 activating enzyme E1 subunit 1
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NECTIN2
|
nectin cell adhesion molecule 2
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIL3
|
nuclear factor, interleukin 3 regulated
|
|
NGFR
|
nerve growth factor receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOG
|
noggin
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP43
|
nucleoporin 43kDa
|
|
NUP62
|
nucleoporin 62kDa
|
|
NUP98
|
nucleoporin 98kDa
|
|
NXT1
|
nuclear transport factor 2-like export factor 1
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OVCA2
|
ovarian tumor suppressor candidate 2
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX5
|
paired box 5
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCGF2
|
polycomb group ring finger 2
|
|
PCLAF
|
PCNA clamp associated factor
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEG10
|
paternally expressed 10
|
|
PFAS
|
phosphoribosylformylglycinamidine synthase
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF8
|
PHD finger protein 8
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIR
|
pirin (iron-binding nuclear protein)
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLG
|
plasminogen
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PRAM1
|
PML-RARA regulated adaptor molecule 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSG2
|
pregnancy specific beta-1-glycoprotein 2
|
|
PSG5
|
pregnancy specific beta-1-glycoprotein 5
|
|
PSG8
|
pregnancy specific beta-1-glycoprotein 8
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMC6
|
proteasome (prosome, macropain) 26S subunit, ATPase, 6
|
|
PTCRA
|
pre T-cell antigen receptor alpha
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTF1A
|
pancreas specific transcription factor, 1a
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPA
|
protein phosphatase 2 phosphatase activator
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PVR
|
poliovirus receptor
|
|
PXDN
|
peroxidasin
|
|
QRSL1
|
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1
|
|
RAB40B
|
RAB40B, member RAS oncogene family
|
|
RAB7B
|
RAB7B, member RAS oncogene family
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RACK1
|
receptor for activated C kinase 1
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RERE
|
arginine-glutamic acid dipeptide (RE) repeats
|
|
RET
|
ret proto-oncogene
|
|
RGCC
|
regulator of cell cycle
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RMDN1
|
regulator of microtubule dynamics 1
|
|
RMDN2
|
regulator of microtubule dynamics 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF112
|
ring finger protein 112
|
|
RNF34
|
ring finger protein 34, E3 ubiquitin protein ligase
|
|
RNF4
|
ring finger protein 4
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RNPEP
|
arginyl aminopeptidase (aminopeptidase B)
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPP14
|
ribonuclease P/MRP 14kDa subunit
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCT
|
secretin
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SENP3
|
SUMO1/sentrin/SMT3 specific peptidase 3
|
|
SEPT6
|
septin 6
|
|
SEPT9
|
septin 9
|
|
SET
|
SET nuclear proto-oncogene
|
|
SF3B6
|
splicing factor 3b, subunit 6, 14kDa
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SH3BP4
|
SH3-domain binding protein 4
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SHB
|
Src homology 2 domain containing adaptor protein B
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMYD5
|
SMYD family member 5
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SP100
|
SP100 nuclear antigen
|
|
SP140
|
SP140 nuclear body protein
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRGN
|
serglycin
|
|
ST13
|
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STMN1
|
stathmin 1
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO2
|
small ubiquitin-like modifier 2
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SVIL
|
supervillin
|
|
SWT1
|
SWT1 RNA endoribonuclease homolog (S. cerevisiae)
|
|
SYBU
|
syntabulin (syntaxin-interacting)
|
|
SYNGR1
|
synaptogyrin 1
|
|
SYT1
|
synaptotagmin I
|
|
TACR1
|
tachykinin receptor 1
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX22
|
T-box 22
|
|
TCEA2
|
transcription elongation factor A (SII), 2
|
|
TCHP
|
trichoplein, keratin filament binding
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFEB
|
transcription factor EB
|
|
TFRC
|
transferrin receptor
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM1
|
transglutaminase 1
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10C
|
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRAP
|
triiodothyronine receptor auxiliary protein
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM16
|
tripartite motif containing 16
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMS
|
thymidylate synthetase
|
|
U2AF1
|
U2 small nuclear RNA auxiliary factor 1
|
|
UBA7
|
ubiquitin-like modifier activating enzyme 7
|
|
UBD
|
ubiquitin D
|
|
UBE2E2
|
ubiquitin-conjugating enzyme E2E 2
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6
|
|
UCN
|
urocortin
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
USP37
|
ubiquitin specific peptidase 37
|
|
USP48
|
ubiquitin specific peptidase 48
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VOPP1
|
vesicular, overexpressed in cancer, prosurvival protein 1
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
WDFY3
|
WD repeat and FYVE domain containing 3
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WIPI1
|
WD repeat domain, phosphoinositide interacting 1
|
|
WIPI2
|
WD repeat domain, phosphoinositide interacting 2
|
|
WLS
|
wntless Wnt ligand secretion mediator
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WT1
|
Wilms tumor 1
|
|
XAB2
|
XPA binding protein 2
|
|
XBP1
|
X-box binding protein 1
|
|
XPO1
|
exportin 1
|
|
XPR1
|
xenotropic and polytropic retrovirus receptor 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB32
|
zinc finger and BTB domain containing 32
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
|
ZMYM2
|
zinc finger, MYM-type 2
|
|
ZNF451
|
zinc finger protein 451
|
|
ZNF645
|
zinc finger protein 645
|
